Related references
Note: Only part of the references are listed.Reproductive Outcomes After Breast Cancer in Women With vs Without Fertility Preservation
Anna Marklund et al.
JAMA ONCOLOGY (2021)
Oncofertility care in young women and the outcomes of pregnancy over the last 5 years
Sayuri Takahashi et al.
FUTURE SCIENCE OA (2021)
Ovarian hyperstimulation closely associated with resumption of follicular growth after chemotherapy during tamoxifen treatment in premenopausal women with breast cancer: a multicenter retrospective cohort study
Rena Yamazaki et al.
BMC CANCER (2020)
Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines
M. Lambertini et al.
ANNALS OF ONCOLOGY (2020)
Nationwide survey of Japanese breast oncology and reproductive endocrinology departments about the impact of breast cancer treatment on fertility
Rena Yamazaki et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2020)
Gonadotropin-releasing hormone agonists during chemotherapy for ovarian function and fertility preservation for patients with early-stage breast cancer
Hikmat Abdel-Razeq
CANCER MANAGEMENT AND RESEARCH (2019)
Pregnancy Outcomes After a Breast Cancer Diagnosis: A Systematic Review and Meta-analysis
Brigitte Gerstl et al.
CLINICAL BREAST CANCER (2018)
The impact of cancer on subsequent chance of pregnancy: a population-based analysis
Richard A. Anderson et al.
HUMAN REPRODUCTION (2018)
Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update
Kutluk Oktay et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Impact of tamoxifen therapy on fertility in breast cancer survivors
Lisa M. Shandley et al.
FERTILITY AND STERILITY (2017)
An updated report on the trends in cancer incidence and mortality in Japan, 1958-2013
Kota Katanoda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2015)
Tamoxifen-induced ovarian hyperstimulation during premenopausal hormonal therapy for breast cancer in Japanese women
Rena Yamazaki et al.
SPRINGERPLUS (2015)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
Christina Davies et al.
LANCET (2013)
Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer
Joseph M. Letourneau et al.
CANCER (2012)
Motherhood after breast cancer: searching for la dolce vita
Hatem A. Azim et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin-and cyclophosphamide followed by a taxane
Yee-Lu Tham et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2007)
American Society of Clinical Oncology recommendations on fertility preservation in cancer patients
Stephanie J. Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)